Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Inhalation Sciences strengthens its US IP position with new patent approval

(Stockholm, October 18, 2023) Innovative Swedish MedTech company Inhalation Sciences Sweden AB (ISAB) has strengthened its IP portfolio in the US relating to PreciseInhale® with approval for a new patent.PreciseInhale®, a unique system with several preclinical exposure modules, has quickly become a natural choice for inhalation scientists worldwide studying how inhaled particles affect the lungs and human health. PreciseInhale® is already protected by key patent rights, but this so-called divisional application further improves this protection in the strategic and important US market.

BioStock: Abliva’s VP of Clinical Operations on the screening achievement

Swedish biotech company Abliva has successfully met the target number of patients for screening in the first wave of the global phase II FALCON study, demonstrating their commitment to maintaining the project’s timeline. BioStock spoke with VP Clinical Operations, Dag Nesse, about this achievement in the study.Read the article at biostock.se: https://www.biostock.se/en/2023/10/ablivas-vp-of-clinical-operations-on-the-screening-achievement/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital18 October 2023 at 9.15 EET Nordea has today cancelled 8,569,610 treasury shares in line with the decision by the Board of Directors. The shares were held for capital optimisation purposes and acquired through share buy-backs. The cancellation brings the total number of shares in Nordea to 3,548,889,720. The total number of votes attached to the shares is 3,548,889,720. The cancellation of the shares was registered with the Finnish Trade Register on 18 October 2023. The company holds 758,535

Liza Jonson winner of Sustainable Leadership Award 2023

Nätverket för Hållbart Näringsliv appoints Liza Jonson, the CEO of Swedbank Robur, as the winner of the Sustainable Leadership Award 2023. The motivation emphasizes her dedication to lead the way towards a more positive and sustainable future, for her own organization, as well as for competitors and the society.“I am delighted to receive this award and immensely proud of the strong commitment demonstrated by everyone at Swedbank Robur. I share this recognition with my great colleagues at Swedbank Robur, who, like me, firmly believe that sustainability will create financial return in the

Videobot expands client base to politics - Luxembourg’s Demokratesch Partei presented its electoral themes to potential voters via video chatbot

The latest video chatbot technology is being utilized to help political parties build trust and engage a wider audience across digital platforms, with multi-language implementation improving the accessibility of information.Luxembourg (October 18th, 2023) As interactive video content continues to gain ground, Finnish-Luxembourgish Videobot  is attracting new clients in the realm of politics. Luxembourg’s liberal Demokratesch Partei  (DP) used Videobot’s technology on its website to present its parliamentary election

Analyst and investor site visit

FIRSTGROUP PLC analyst and investor site visit   FirstGroup plc (‘the Group') is today hosting an analyst and investor event at its First Bus depot in Leicester to provide detail on the electrification of the First Bus fleet and infrastructure.   The Group has accelerated its investment in electrification as First Bus progresses towards its 2035 decarbonisation target; in FY 2024 alone, the Group has committed net investment of £105m for electric buses and infrastructure, supported by co-funding of £82m. We will have more than 600 electric buses (c.15% of our fleet) and four

Elkem ASA - Invitation to third quarter 2023 results presentation

Oslo, 18 October 2023 Elkem ASA will release its report for the third quarter 2023 on Wednesday, 25 October at 7.00 a.m. CET. The quarterly report and presentation material will be made available at this time at www.elkem.com In connection with the quarterly report, the company will host a presentation at 9.00 a.m. CET. The event will take place in Auditoriet, Haakon Vll gate 2, Oslo. The third quarter presentation can also be viewed in a live webcast at Elkem Webcast Q3 2023  or via www.elkem.com The

MAG Interactive AB (publ) publishes Interim and Year-End Report September – August 2022/2023

MAG Interactive’s net sales reached 80 MSEK in Q4, a decrease of 11% compared to the same quarter the previous year. Adjusted EBITDA grew to 25 MSEK, resulting in an adjusted EBITDA-margin of 31%. The annual net sales grew to 362 MSEK with an adjusted EBITDA of 58 MSEK.Summary of the period June 2023 – August 2023: · Adjusted EBITDA for the period was 25,010 KSEK (4,719 KSEK) an increase of 20,291 KSEK · The Group's Net sales for the period was 80,095 KSEK (90,001 KSEK) a decrease of 11% · The Group's game contribution for the period was 53,942 KSEK (34,894 KSEK), an increase of

Letter from MindArk's CEO, Q4 2023

Dear shareholders, Without doubt, quite a lot has happened since the last CEO letter. In September, Unionen's magazine Kollega published an article about MindArk, stating that we are replacing staff with AI, a somewhat simplified picture compared to what we communicated on May 30, 2023. The day after, the article exploded in the media - MindArk was on the front pages of several newspapers and was mentioned in nationwide news coverage. For the media, MindArk became perhaps the first Swedish societal example in the debate on how companies adapt their organizations by embracing

Spinnova unveils sustainable denim at Kingpins trade show

Sustainable textile material company Spinnova presented the first blended denim fabrics made with SPINNOVA® fibre. Using Spinnova’s unique technology, the SPINNOVA® fibre for the denim is produced without harmful chemicals and its CO2 emissions and water consumption are significantly lower compared to conventional cotton production* – presenting a less resource-intensive way of making jeans without compromising the sturdy feel and aesthetics of denim. With a global market of 3.1 billion pairs in 2022, denim jeans could easily be considered a wardrobe staple. Despite this, there

Director Appointment

  N E W S   R E L E A S E     Looking Glass Labs Announces Director Appointment     Vancouver, British Columbia – 18 October 2023 / Globe Newswire / – Looking Glass Labs Ltd. (“LGL” or the “Company”) (NEO: NFTX) (AQSE: NFTX) (OTC: LGSLF) (FRA: H1N), a leading Web3 platform specialising in non-fungible token (“NFT”) architecture, immersive metaverse environments, play-to-earn tokenisation and virtual asset royalty streams, announces that Lucas Stemshorn-Russell has resigned as a director with immediate effect. The Company wishes to thank Mr. Stemshorn-Russell

BioStock Life Science Fall Summit - one week away!

On October 25 & 26 it is once again time for the go-to life science partnering event in the Nordics: the BioStock Life Science Fall Summit! The packed two-day event, at Medicon Village in Lund, featurs around 40 thrilling life science companies showcasing their projects and innovations to investors and potential partners. The Summit also gives space for Expert Insights sessions, where industry experts and investors will offer their valuable advice and experiences.Have you noticed any trends on the stock markets lately? How are listed life science companies handling the current financial

Gradientech expands its distribution network in Europe

The diagnostic company Gradientech today announces an exclusive distribution agreement with Iberlab for the commercialisation of QuickMIC® in Portugal.Iberlab is a leading supplier of diagnostic solutions and consumables to clinical laboratories on the Portuguese market. "At Iberlab, we aim to meet our customers’ requirements at the highest level. It is our strong ambition to provide diagnostic solutions to satisfy the needs of the clinical laboratory. Adding the product line from Gradientech is therefore a strong addition to our portfolio. The QuickMIC system fits our focus perfect as we

Equativ Integrates NinaData’s Generative AI Audiences to Enhance Consumer Buying Intent Prediction

Equativ's Buyer Connect platform, together with NinaData's large language model (LLM) for predictive buying, shows advertisers exactly where to reach their audiences – in a 100% privacy-first environment.Finnish buying intent data platform, NinaData , has announced its integration with Equativ , the leading independent adtech platform. NinaData's advanced contextual targeting and buying intent capabilities are now available in Equativ’s Buyer Connect (EBC) digital ad curation platform – enabling media buyers to more effectively target their

Notice to attend the Extraordinary General Meeting of John Mattson Fastighetsföretagen AB (publ)

The shareholders of John Mattson Fastighetsföretagen AB (publ), reg. no. 556802-2858 (“John Mattson” or the “Company”), are hereby given notice of the Extraordinary General Meeting (the “EGM”) on 21 November 2023 at 2:00 p.m. in Malmstensalen at Campus Lidingö (Malmstenskolan), Larsbergsvägen 8, Lidingö. Entry and registration commences at 1:30 p.m.Right to participate at the EGM Shareholders wishing to participate at the EGM must: · be entered in the share register maintained by Euroclear Sweden AB ("Euroclear") on 13 November 2023, or alternatively, if the shares are nominee-

Nixu Corporation: CEO’s review for Q3 2023

Nixu Corporation Stock Exchange Release, October 18, 2023, at 8:30 am EESTMacroeconomic situation continues to impact growth July–September 2023: · Revenue EUR 13.1 million (Q3/2022: EUR 14.4 million); change -9% · EBIT EUR -805 thousand (Q3/2022: EUR 642 thousand) · Adjusted EBIT EUR -548 thousand (Q3/2022: EUR 642 thousand) January–September 2023: · Revenue EUR 45.0 million (Q3/2022: EUR 43.0 million); growth 5% · EBIT EUR -1,888 thousand (Q3/2022: EUR 88 thousand) · Adjusted EBIT EUR 159 thousand (Q3/2022: EUR 63 thousand) Financial guidance for 2023:

PharmNovo signs agreement with Worldwide Clinical Trials for phase IIa study of PN6047 in neuropathic pain

PharmNovo, a Swedish pharmaceutical company developing neuropathic pain treatments, announces its collaboration with Worldwide Clinical Trials, a full-service contract research organisation (CRO), to conduct the phase IIa study of PN6047.The study is planned to start in 2024.In the upcoming phase IIa study, PharmNovo will investigate the safety, tolerability, pharmacokinetics, and efficacy of their drug candidate PN6047 for individuals affected by neuropathic pain and experiencing Mechanical Allodynia. This distressing symptom, caused by nerve injury, often disrupts daily life and sleep.

The Board of Directors of John Mattson has resolved on a fully guaranteed rights issue of approximately SEK 1,250 million to strengthen its financial position and enable value-creating investments

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER COUNTRY OR JURISDICTION TO WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS OR WOULD REQUIRE THE PREPARATION OR REGISTRATION OF ADDITIONAL DOCUMENTATION OR REQUIRE ANY OTHER ACTION TO BE TAKEN, IN ADDITION TO THE REQUIREMENTS OF SWEDISH LAW. THIS PRESS RELEASE IS NOT A PROSPECTUS BUT AN ANNOUNCEMENT IN CONNECTION WITH THE PLANNED NEW ISSUE OF

Curasight A/S reports positive preclinical results with uTREAT[®] in lung cancer (NSCLC)

· Preclinical studies show uTREAT[®] effective in treating non-small cell lung cancer (NSCLC) · Data follows recent announcement of positive preclinical results within glioblastoma and supports hypothesis that uTREAT[®] has treatment potential in additional solid tumors · Data highlights potential of company’s uPAR theranostic platform to combine diagnosis (uTRACE[®]) with more gentle and targeted treatment (uTREAT[®]) Copenhagen, October 18, 2023 - Curasight A/S (“Curasight” or “the Company” – TICKER: CURAS) is pleased to announce preclinical data demonstrating preclinical proof

Volvo Group – the third quarter 2023

“In Q3 2023, the Volvo Group continued to deliver improved results, margins and profitability. Adjusted for currency, our net sales grew by 9% to SEK 132.4 billion and we increased the adjusted operating income to SEK 19.1 billion (11.9), corresponding to an adjusted operating margin of 14.4% (10.3). We have successfully mitigated cost inflation with price management and continued to handle disturbances in the supply chain. Return on capital employed increased to 33.7% (27.4),” says Martin Lundstedt, President and CEO.· In Q3 2023, net sales increased by 15% to SEK 132.4 billion (114.9).

BlueNord Announce Third Quarter 2023 Results

Oslo, 18 October 2023: BlueNord ASA ("BlueNord" or the "Company") today published its third quarter 2023 results. During the quarter, the Company delivered strong operational and financial performance.  Tyra II de-risking continued and BlueNord now expects the revised start-up strategy to accelerate plateau production into Q2 2024, delivering greater volumes from Tyra during 2024 than what was previously communicated through the Company’s long-term production outlook.   Highlights: · Second quarter net hydrocarbon production of 24.7 mboepd, in upper end of quarterly guidance ·

Handelsbanken’s Interim Report January – September 2023

· Operating profit increased by 42% to SEK 27,265m (19,251) · Return on equity increased to 16.2% (12.5) · The C/I ratio improved to 36.8% (42.3) · Continued good credit quality with a credit loss ratio of 0.01% (0.00) · Strong financial position with a common equity tier 1 ratio of 19.4% (19.0)  * Items affecting comparability: Reversal of VAT paid in conjunction with sale of card acquiring operations (other income) SEK 141m and (net fee and commission income) SEK 17m (Q2 2023); funding cost relating to discontinued operations in Finland (net interest income)

Aker Carbon Capture awarded feasibility study by major waste-to-energy player in France

Aker Carbon Capture has been awarded a feasibility study to implement carbon capture at a waste-to-energy facility in France. The planned capture capacity will be approximately 200,000 tonnes CO2 per year and will be based on two Just Catch 100 carbon capture units. Year-to-date, Aker Carbon Capture has now contracted studies, Mobile Test Unit campaigns and pre-FEEDs for a combined capture capacity of 8.7 million tonnes of CO2 per year.“We are excited to be working on this decarbonization project, which will be Aker Carbon Capture’s first study in France. Carbon capture, usage, and storage (

Camurus’ Nomination Committee appointed for the Annual General Meeting 2024

Lund — 18 October 2023 — Camurus today announced that the Nomination Committee for the Annual General Meeting (AGM), 2024 consists of the following persons, who together represent about 47.9 percent of the total number of shares and votes in Camurus based on the last known shareholder information: · Per Sandberg, appointed by Sandberg Development AB, · Arne Lööw, appointed by Fjärde AP-fonden, · Magnus Welander, appointed by Fredrik Tiberg, and · Per Olof Wallström, Chairman of the Board of Camurus The Nomination Committee’s proposals will be presented in the Notice to the

There are no items matching the current filter
There are no more items matching the current filter
Back to top